开发一种含有1,2,4-三的新型化合物,具有抗癌和强烈的抗CB1活性
Sümbül Yıldırım1, Aslıhan Ayvaz2, Arif Mermer3,4,5
1Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul, Turkey.
Journal of biomolecular structure & dynamics
|July 28, 2023
概括
新的1,2,4-三醇化合物对胰腺和前列腺癌细胞具有显著的抗癌活性. 这些化合物还表现出抗CB1活性,为新的治疗策略提供了潜力.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 癌症研究 癌症研究
背景情况:
- 对于新型抗癌剂的持续需求.
- 含的异环,特别是1,2,4-triazoles,因其强大的抗癌性质而闻名.
- 1,2,4-三醇具有有利的物理化学特性,可以与生物标相互作用.
研究的目的:
- 通过绿色化学方法合成新的1,2,4-triazole衍生物.
- 为了评估这些化合物对人类癌症细胞系的抗癌活性.
- 研究这些化合物作为CB1抗剂的潜力.
主要方法:
- 通过微波辐射和超声波合成1,2,4-三衍生物.
- 绿色化学原理和指标的应用,用于合成评估.
- 在体外对PANC1 (胰腺),DU145 (前列腺),MCF7 (乳腺) 癌细胞系和HDF纤维细胞进行检测.
主要成果:
- 化合物5e和5f与CB1抗剂具有结构上的相似性.
- 化合物5e-g对PANC1和DU145细胞表现出显著的细胞毒性,IC50值在5.9至7.3μM之间.
- 化合物5e-g在癌细胞的S阶段诱导细胞循环停止.
- 在正常的HDF细胞中也观察到细胞毒性.
结论:
- 成功开发了具有双重抗癌和抗CB1活性的新型1,2,4-triazole化合物.
- 绿色化学方法在合成这些有前途的抗癌剂方面被证明是有效的.
- 对这些化合物的进一步研究可能会导致癌症治疗的新疗法.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
319
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
319
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
342
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
342
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
201
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
201


